US-based healthcare company Johnson & Johnson (J&J) has signed a corporate power purchase agreement (CPPA) with Danish energy firm Ørsted to provide electricity for its operations in Ireland.

Under the CPPA, Ørsted will supply more than 1TWh of renewable energy from two wind farms located in Kilgarvan, County Kerry, and Booltiagh, County Clare, over a period of eight years.

The clean energy will be used to power J&J’s ten sites in Ireland, including DePuy Ireland , Janssen Sciences, Janssen Pharmaceutical and J&J Vision Care.

J&J Vision Care Ireland plant leader John Lynch said: “We are proud to announce that we have reached our target of sourcing 100% of our electricity across our Irish operations from renewable sources.

“Across our ten sites and workforce of more than 5,000 here in Ireland, we are committed to supporting Johnson & Johnson’s climate action goals.”

Lynch said that J&J has invested more than €60m ($69m) in more than 80 carbon footprint reduction projects over the last ten years.

The latest agreement will allow J&J to power all its operations in Ireland with green electricity, as well as helping Ørsted make further investments to increase renewable energy generation in the future.

It comes after J&J signed three separate virtual power purchase agreements in Europe recently.

Irish Taoiseach Micheál Martin said: “Johnson & Johnson has embraced its environmental responsibilities globally, but also here in Ireland, and this agreement will help the company to achieve its wider climate goals.

“We are at a crucial point in the global fight against climate change and initiatives like this should become the benchmark for all companies to aspire to.”

In April, Ørsted acquired Brookfield Renewable Ireland (BRI), an onshore wind operator based in the UK and Ireland.

The acquisition marked the company’s first onshore venture in Europe, having begun onshore operations in the US in 2018.